Rifaximin
本品由扬州市三药制药有限公司生产，批准文号为国药准字H20070299，符合YBH05842007质量标准。
- 产品描述
- Parameters
-
本品由扬州市三药制药有限公司生产，批准文号为国药准字H20070299，符合YBH05842007质量标准。
Rifaximin, a rifamycin derivative, is the first non-aminoglycoside intestinal antibiotic.
This product has a strong effect and a wide antibacterial spectrum.
This product is highly active against Staphylococcus pyogenes, Staphylococcus epidermidis and Streptococcus faecalis in gram-positive aerobic bacteria; Salmonella, Escherichia, Escherichia coli, Gram-negative oxygen bacteria; and Bacteroidetes in Gram-negative anaerobes.
This product is produced by Yangzhou Santai Pharmaceutical Co., Ltd. The approval number is H20070299, which meets the YBH05842007 quality standard.
Follow
沪公网安备 31011202002328号 Internet drug information service qualification certificate: (Qiong) - non operational-2023-0023
